Industry: Service & Software
Published Date: 2025-01-19
Pages: 112 Pages
Report ld: 3429851
Request Sample
Customized Report
Oocyte Cryopreservation Market Size(US$)

CAGR 2025-2031
15%
Market Size,2031
USD 242
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Oocyte Cryopreservation was estimated to be worth US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Human oocyte cryopreservation (egg freezing) is a procedure to preserve a woman's eggs (oocytes).The eggs are extracted, frozen and stored. The intention of the procedure is that the woman may choose to have the eggs thawed, fertilized, and transferred to the uterus as embryos to facilitate a pregnancy in the future.
America is the largest region market with more than 75% market share in oocyte cryopreservation industry in Canada and USA regions. Top players are Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates, CCRM IVF, HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group), Kindbody, West Coast Fertility Centers etc.
The driving factors of the oocyte cryopreservation market mainly include the following aspects:
Technological progress: The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.
Changes in fertility concepts: The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.
Growth in medical demand: With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.
Policy support: The support policies for assisted reproductive technology in some countries and regions, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.
This report aims to provide a comprehensive presentation of the global market for Oocyte Cryopreservation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oocyte Cryopreservation by region & country, by Type, and by Customer.
The Oocyte Cryopreservation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oocyte Cryopreservation.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oocyte Cryopreservation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Customer, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Oocyte Cryopreservation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Oocyte Cryopreservation in country level. It provides sigmate data by Type, and by Customer for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Oocyte Cryopreservation Product Introduction
1.2 Global Oocyte Cryopreservation Market Size Forecast (2020-2031)
1.3 Oocyte Cryopreservation Market Trends & Drivers
1.3.1 Oocyte Cryopreservation Industry Trends
1.3.2 Oocyte Cryopreservation Market Drivers & Opportunity
1.3.3 Oocyte Cryopreservation Market Challenges
1.3.4 Oocyte Cryopreservation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oocyte Cryopreservation Players Revenue Ranking (2024)
2.2 Global Oocyte Cryopreservation Revenue by Company (2020-2025)
2.3 Key Companies Oocyte Cryopreservation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oocyte Cryopreservation Product Offered
2.5 Key Companies Time to Begin Mass Production of Oocyte Cryopreservation
2.6 Oocyte Cryopreservation Market Competitive Analysis
2.6.1 Oocyte Cryopreservation Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Oocyte Cryopreservation Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oocyte Cryopreservation as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Slow-cooling Method
3.1.2 Flash-freezing Process (Vitrification)
3.2 Global Oocyte Cryopreservation Sales Value by Type
3.2.1 Global Oocyte Cryopreservation Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Oocyte Cryopreservation Sales Value, by Type (2020-2031)
3.2.3 Global Oocyte Cryopreservation Sales Value, by Type (%) (2020-2031)
4 Segmentation by Customer
4.1 Introduction by Customer
4.1.1 25-30 Year Old Female
4.1.2 30-35 Year Old Female
4.1.3 35-40 Year Old Female
4.1.4 Others
4.2 Global Oocyte Cryopreservation Sales Value by Customer
4.2.1 Global Oocyte Cryopreservation Sales Value by Customer (2020 VS 2024 VS 2031)
4.2.2 Global Oocyte Cryopreservation Sales Value, by Customer (2020-2031)
4.2.3 Global Oocyte Cryopreservation Sales Value, by Customer (%) (2020-2031)
5 Segmentation by Region
5.1 Global Oocyte Cryopreservation Sales Value by Region
5.1.1 Global Oocyte Cryopreservation Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Oocyte Cryopreservation Sales Value by Region (2020-2025)
5.1.3 Global Oocyte Cryopreservation Sales Value by Region (2026-2031)
5.1.4 Global Oocyte Cryopreservation Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Oocyte Cryopreservation Sales Value, 2020-2031
5.2.2 North America Oocyte Cryopreservation Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Oocyte Cryopreservation Sales Value, 2020-2031
5.3.2 Europe Oocyte Cryopreservation Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Oocyte Cryopreservation Sales Value, 2020-2031
5.4.2 Asia Pacific Oocyte Cryopreservation Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Oocyte Cryopreservation Sales Value, 2020-2031
5.5.2 South America Oocyte Cryopreservation Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oocyte Cryopreservation Sales Value, 2020-2031
5.6.2 Middle East & Africa Oocyte Cryopreservation Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oocyte Cryopreservation Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Oocyte Cryopreservation Sales Value, 2020-2031
6.3 United States
6.3.1 United States Oocyte Cryopreservation Sales Value, 2020-2031
6.3.2 United States Oocyte Cryopreservation Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Oocyte Cryopreservation Sales Value by Customer, 2024 VS 2031
6.4 Europe
6.4.1 Europe Oocyte Cryopreservation Sales Value, 2020-2031
6.4.2 Europe Oocyte Cryopreservation Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Oocyte Cryopreservation Sales Value by Customer, 2024 VS 2031
6.5 China
6.5.1 China Oocyte Cryopreservation Sales Value, 2020-2031
6.5.2 China Oocyte Cryopreservation Sales Value by Type (%), 2024 VS 2031
6.5.3 China Oocyte Cryopreservation Sales Value by Customer, 2024 VS 2031
6.6 Japan
6.6.1 Japan Oocyte Cryopreservation Sales Value, 2020-2031
6.6.2 Japan Oocyte Cryopreservation Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Oocyte Cryopreservation Sales Value by Customer, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Oocyte Cryopreservation Sales Value, 2020-2031
6.7.2 South Korea Oocyte Cryopreservation Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Oocyte Cryopreservation Sales Value by Customer, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Oocyte Cryopreservation Sales Value, 2020-2031
6.8.2 Southeast Asia Oocyte Cryopreservation Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Oocyte Cryopreservation Sales Value by Customer, 2024 VS 2031
6.9 India
6.9.1 India Oocyte Cryopreservation Sales Value, 2020-2031
6.9.2 India Oocyte Cryopreservation Sales Value by Type (%), 2024 VS 2031
6.9.3 India Oocyte Cryopreservation Sales Value by Customer, 2024 VS 2031
7 Company Profiles
7.1 Prelude Fertility
7.1.1 Prelude Fertility Profile
7.1.2 Prelude Fertility Main Business
7.1.3 Prelude Fertility Oocyte Cryopreservation Products, Services and Solutions
7.1.4 Prelude Fertility Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.1.5 Prelude Fertility Recent Developments
7.2 CReATe Fertility Center
7.2.1 CReATe Fertility Center Profile
7.2.2 CReATe Fertility Center Main Business
7.2.3 CReATe Fertility Center Oocyte Cryopreservation Products, Services and Solutions
7.2.4 CReATe Fertility Center Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.2.5 CReATe Fertility Center Recent Developments
7.3 Anova Fertility
7.3.1 Anova Fertility Profile
7.3.2 Anova Fertility Main Business
7.3.3 Anova Fertility Oocyte Cryopreservation Products, Services and Solutions
7.3.4 Anova Fertility Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.3.5 Anova Fertility Recent Developments
7.4 San Diego Fertility Center (SDFC)
7.4.1 San Diego Fertility Center (SDFC) Profile
7.4.2 San Diego Fertility Center (SDFC) Main Business
7.4.3 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Products, Services and Solutions
7.4.4 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.4.5 San Diego Fertility Center (SDFC) Recent Developments
7.5 Extend Fertility
7.5.1 Extend Fertility Profile
7.5.2 Extend Fertility Main Business
7.5.3 Extend Fertility Oocyte Cryopreservation Products, Services and Solutions
7.5.4 Extend Fertility Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.5.5 Extend Fertility Recent Developments
7.6 Shady Grove Fertility
7.6.1 Shady Grove Fertility Profile
7.6.2 Shady Grove Fertility Main Business
7.6.3 Shady Grove Fertility Oocyte Cryopreservation Products, Services and Solutions
7.6.4 Shady Grove Fertility Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.6.5 Shady Grove Fertility Recent Developments
7.7 Mayo Clinic
7.7.1 Mayo Clinic Profile
7.7.2 Mayo Clinic Main Business
7.7.3 Mayo Clinic Oocyte Cryopreservation Products, Services and Solutions
7.7.4 Mayo Clinic Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.7.5 Mayo Clinic Recent Developments
7.8 Reproductive Biology Associates
7.8.1 Reproductive Biology Associates Profile
7.8.2 Reproductive Biology Associates Main Business
7.8.3 Reproductive Biology Associates Oocyte Cryopreservation Products, Services and Solutions
7.8.4 Reproductive Biology Associates Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.8.5 Reproductive Biology Associates Recent Developments
7.9 CCRM IVF
7.9.1 CCRM IVF Profile
7.9.2 CCRM IVF Main Business
7.9.3 CCRM IVF Oocyte Cryopreservation Products, Services and Solutions
7.9.4 CCRM IVF Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.9.5 CCRM IVF Recent Developments
7.10 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
7.10.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Profile
7.10.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Main Business
7.10.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Products, Services and Solutions
7.10.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.10.5 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Developments
7.11 Kindbody
7.11.1 Kindbody Profile
7.11.2 Kindbody Main Business
7.11.3 Kindbody Oocyte Cryopreservation Products, Services and Solutions
7.11.4 Kindbody Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.11.5 Kindbody Recent Developments
7.12 West Coast Fertility Centers
7.12.1 West Coast Fertility Centers Profile
7.12.2 West Coast Fertility Centers Main Business
7.12.3 West Coast Fertility Centers Oocyte Cryopreservation Products, Services and Solutions
7.12.4 West Coast Fertility Centers Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.12.5 West Coast Fertility Centers Recent Developments
7.13 Ruizhimei
7.13.1 Ruizhimei Profile
7.13.2 Ruizhimei Main Business
7.13.3 Ruizhimei Oocyte Cryopreservation Products, Services and Solutions
7.13.4 Ruizhimei Oocyte Cryopreservation Revenue (US$ Million) & (2020-2025)
7.13.5 Ruizhimei Recent Developments
8 Industry Chain Analysis
8.1 Oocyte Cryopreservation Industrial Chain
8.2 Oocyte Cryopreservation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oocyte Cryopreservation Sales Model
8.5.2 Sales Channel
8.5.3 Oocyte Cryopreservation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Oocyte Cryopreservation market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 274 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 97
USD 4250.00
(Single User License)
The global Oocyte Cryopreservation market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 274 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 2900.00
(Single User License)
The global market for Oocyte Cryopreservation was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 274 million, growing at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 110
USD 3950.00
(Single User License)
The global Oocyte Cryopreservation market size was US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 93
USD 4250.00
(Single User License)
The global Oocyte Cryopreservation market is projected to grow from US$ 92 million in 2024 to US$ 242 million by 2031, at a CAGR of 15.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 140
USD 4900.00
(Single User License)
The global market for Oocyte Cryopreservation was valued at US$ 92 million in the year 2024 and is projected to reach a revised size of US$ 242 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published Date: 2025-01-19
Pages: 90
USD 2900.00
(Single User License)
The global Oocyte Cryopreservation revenue was US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published Date: 2024-11-29
Pages: 113
USD 4350.00
(Single User License)
The global market for Oocyte Cryopreservation was estimated to be worth US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published Date: 2024-11-29
Pages: 104
USD 3950.00
(Single User License)
Valued at US$ 92 million in 2024, the global Oocyte Cryopreservation market is forecast to reach US$ 213 million by 2030, at a CAGR of 15.0% during the forecast period.
Published Date: 2024-11-29
Pages: 142
USD 4900.00
(Single User License)
The global market for Oocyte Cryopreservation was valued at US$ 81 million in the year 2023 and is projected to reach a revised size of US$ 213 million by 2030, growing at a CAGR of 15.0% during the forecast period.
Published Date: 2024-11-29
Pages: 90
USD 2900.00
(Single User License)
The global Oocyte Cryopreservation market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 274 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 97
The global Oocyte Cryopreservation market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 274 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
The global market for Oocyte Cryopreservation was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 274 million, growing at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 110
The global Oocyte Cryopreservation market size was US$ 92 million in 2024 and is forecast to a readjusted size of US$ 242 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 93
The global Oocyte Cryopreservation market is projected to grow from US$ 92 million in 2024 to US$ 242 million by 2031, at a CAGR of 15.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 140
The global market for Oocyte Cryopreservation was valued at US$ 92 million in the year 2024 and is projected to reach a revised size of US$ 242 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published: 2025-01-19
Pages: 90
The global Oocyte Cryopreservation revenue was US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published: 2024-11-29
Pages: 113
The global market for Oocyte Cryopreservation was estimated to be worth US$ 81 million in 2023 and is forecast to a readjusted size of US$ 213 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published: 2024-11-29
Pages: 104
Valued at US$ 92 million in 2024, the global Oocyte Cryopreservation market is forecast to reach US$ 213 million by 2030, at a CAGR of 15.0% during the forecast period.
Published: 2024-11-29
Pages: 142
The global market for Oocyte Cryopreservation was valued at US$ 81 million in the year 2023 and is projected to reach a revised size of US$ 213 million by 2030, growing at a CAGR of 15.0% during the forecast period.
Published: 2024-11-29
Pages: 90
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now